Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trialAimery de Gramont, Paulo M. Hoff, Stephen Clarke et al.|The Lancet Oncology|2012Cited by 526
First-line chemoimmunotherapy and immunotherapy in patients with non-small cell lung cancer and brain metastases: a registry studyLauren Brown, Benjamin Y. Kong, Victor Khou et al.|Frontiers in Oncology|2024Cited by 6